z-logo
Premium
Synthesis and In Vitro Activity of Polyhalogenated 2‐phenylbenzimidazoles as a New Class of anti‐ MRSA and Anti‐ VRE Agents
Author(s) -
Göker Hakan,
Karaaslan Cigdem,
Püsküllü Mustafa Orhan,
Yildiz Sulhiye,
Duydu Yalcin,
Üstündağ Aylin,
Yalcin Can Özgür
Publication year - 2016
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12623
Subject(s) - enterococcus faecium , staphylococcus aureus , microbiology and biotechnology , vancomycin , enterococcus , in vitro , antibiotics , chemistry , methicillin resistant staphylococcus aureus , minimum inhibitory concentration , bacteria , biology , biochemistry , genetics
A series of novel polyhalogenated 2‐phenylbenzimidazoles have been synthesized and evaluated for in vitro antistaphylococcal activity against drug‐resistant bacterial strains (methicillin‐resistant Staphylococcus aureus, and vancomycin‐resistant Enterococcus faecium . Certain compounds inhibit bacterial growth perfectly. 11 was active than vancomycin (0.78  μ g/ mL ) with the lowest MIC values with 0.19  μ g/ mL against methicillin‐resistant Staphylococcus aureus , 8 and 35 exhibited best inhibitory activity against vancomycin‐resistant Enterococcus faecium (1.56  μ g/ mL ). The mechanism of action for this class of compounds appears to be different than clinically used antibiotics. These polyhalogenated benzimidazoles have potential for further investigation as a new class of potent anti‐methicillin‐resistant Staphylococcus aureus and anti‐vancomycin‐resistant Enterococcus faecium agents.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom